Poland· PL-100211722
Afinitor
A everolimus product containing everolimusum, registered in Poland by Novartis Europharm Limited. The same ATC class is registered in 11 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Everolimus is registered in 11 of 19 countries.
Countries holding a registration under ATC L01EG02 (everolimus), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 8 of them publish a price we can compare per daily dose
Everolimus · ATC L01EG02
11 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
Price per daily dose
What a daily dose of everolimus costs, country by country.
Normalised to the WHO defined daily dose (10 mg), the median price runs from $27.93 in United States to $142.94 in Switzerland — a ×5.1 gap.
- 4 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
- US figures are pharmacy acquisition cost (CMS NADAC), not retail
Everolimus · price per daily dose (10 mg)
USD · FX 28 Sept 2026
- CH Switzerland$142.94
- IT Italy$125.91
- ES Spain$105.57
- US United States$27.93 (acquisition cost)
The record
At a glance
URPL (Poland)- Active substance
- Everolimusum
- Manufacturer
- Novartis Europharm Limited
- Country
- Poland (PL)
- ATC code
- L01EG02
- ATC class
- Everolimus
- Defined daily dose
- 10 mg, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 4
- gtin05909990711598
- gtin05909990711604
- gtin05909990711628
- gtin05909990743360
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
428 interactions on record for everolimus.
Graded by severity as the source publishes them — 165 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Everolimus · interactions on record
428 records
- 165 severe
- 255 moderate
- 8 minor
Most severe, free to view
- AprepitantA04AD12severe
- NeomycinA07AA01severe
- StreptomycinA07AA04severe
- Polymyxin BA07AA05severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Everolimus in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaAFINITORNovartis Europharm Limited, Dublin
- NetherlandsAfinitor 10 mg, tablettenNovartis Europharm Limited
- United StatesAfinitorNovartis Pharmaceuticals Corporation
- SpainAFINITOR 10 MG COMPRIMIDOSNovartis Europharm Limited
- SwedenAfinitor 10 mg TablettNovartis Europharm Limited
- FinlandAfinitorNovartis Europharm Limited
- United KingdomAfinitor 10mg tabletsNovartis Pharmaceuticals UK Ltd
- FranceAFINITOR 10 mg, comprimésNOVARTIS EUROPHARM (IRLANDE)
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Certican, Everolimus Ethypharm
- Belgium · Certican, Everolimus Eg
- Bulgaria · Еверолимус Крка, Еверолимус Майлан
- Cyprus · Certican, Everolimus Pharmazac
- Czechia · Certican, Everolimus Accord
- Germany · Certican, Everofin
- Denmark · Certican, Everolimus Krka
- Estonia · Certican, Everolimus Krka
- Spain · Certican, Everolimus Accord
- Finland · Aderolio, Certican
- France · Certican, Everolimus Arrow
- United Kingdom (Northern Ireland) · Aderolio, Aderolio 250 Mcg Tablets
- Greece · Certican, Everolimus Faran
- Croatia · Certican, Everolimus Krka
- Hungary · Certican, Everolimus Accord
- Ireland · Certican, Everolimus Tad
- Iceland · Afinitor, Certican
- Italy · Certican, Everolimus Accord
- Liechtenstein · Afinitor, Votubia
- Lithuania · Certican, Everolimus Norameda
- Luxembourg · Certican, Everolimus Eg
- Latvia · Certican, Everolimus Norameda
- Malta · Certican, Everolimus Ascend
- Netherlands · Certican, Certican Dispers
- Norway · Afinitor, Certican
- Portugal · Certican, Everolimus Ethypharm
- Romania · Certican, Everolimus Accord
- Sweden · Certican, Everolimus Avansor
- Slovenia · Certican, Everolimus Krka
- Slovakia · Certican, Everolimus Accord
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/54bac710-7166-4abe-8108-61d69b555d43 GET /v1/drugs/54bac710-7166-4abe-8108-61d69b555d43?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki",
"source": "urpl",
"strength": "10 mg",
"packaging": "05909990711598 ¦ Rpz ¦ EU/1/09/538/004 ¦ 51412\n30 tabl.\n05909990711604 ¦ Rpz ¦ Skasowane ¦ EU/1/09/538/005 ¦ 51413\n60 tabl.\n05909990711628 ¦ Rpz ¦ EU/1/09/538/006 ¦ 51414\n90 tabl.\n05909990743360 ¦ Rpz ¦ EU/1/09/538/008 ¦ 54359\n10 tabl.",
"substance": "Everolimusum 10 mg",
"common_name": "Everolimusum",
"pl_product_id": "100211722",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about everolimus.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.